A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Mercilon.

PHASE3CompletedINTERVENTIONAL

Enrollment

1,517

Participants

Timeline

Start Date

October 31, 1997

Study Completion Date

March 31, 1999

Conditions

Contraception

Interventions

DRUG

norelgestromin + ethinyl estradiol; mercilon

All Listed Sponsors

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00236782 - A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Mercilon. | Biotech Hunter | Biotech Hunter